Mimedx (MDXG) Change in Account Payables (2012 - 2026)
Mimedx (MDXG) reported Change in Account Payables of $1.9 million for Q1 2026, up 32.6% on a YoY basis from $1.5 million in Q1 2025, and up 222.07% sequentially from -$1.6 million in Q4 2025.
Mimedx (MDXG) Change in Account Payables (2012 - 2026) Analysis & Trends
Mimedx (MDXG) has 15 years of Change in Account Payables data on file, last reported at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 32.6% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 1213.73% YoY), and the FY2025 full-year result was $2.1 million, up 250.28% from the prior year.
- Change in Account Payables advanced to $1.9 million in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q3 2025 to a low of -$1.6 million in Q4 2025.
- A 5-year average of $251000.0 and a median of $283000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 6878.57% in 2023 and plunged 330.68% in 2024, its largest moves.
- Tracing MDXG's Change in Account Payables over 5 years: stood at -$251000.0 in 2022, then jumped by 126.69% to $67000.0 in 2023, then soared by 964.18% to $713000.0 in 2024, then tumbled by 322.44% to -$1.6 million in 2025, then surged by 222.07% to $1.9 million in 2026.
- Business Quant data shows MDXG's Change in Account Payables at $1.9 million in Q1 2026, -$1.6 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | -1.59 Mn |
| Dec 31, 2025 | -1.59 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | -668,000.00 |
| Jun 30, 2025 | -668,000.00 |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 713,000.00 |
| Dec 31, 2024 | 713,000.00 |
| Sep 30, 2024 | -1.05 Mn |
| Sep 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | 283,000.00 |
| Mar 31, 2024 | 283,000.00 |
| Dec 31, 2023 | 67,000.00 |
| Dec 31, 2023 | 67,000.00 |